• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高通量筛选海洋化合物库发现 Leiodolide A 的抗活性。

High-Throughput Screening of a Marine Compound Library Identifies Anti- Activity of Leiodolide A.

机构信息

Department of Veterinary Microbiology and Pathology, College of Veterinary Medicine, Washington State University, 100 Dairy Rd, Pullman, WA 99164, USA.

Harbor Branch Oceanographic Institute, Florida Atlantic University, 5600 US Highway 1 North, Fort Pierce, FL 34946, USA.

出版信息

Mar Drugs. 2022 Mar 30;20(4):240. doi: 10.3390/md20040240.

DOI:10.3390/md20040240
PMID:35447913
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9026894/
Abstract

sp. are apicomplexan parasites that cause significant morbidity and possible mortality in humans and valuable livestock. There are no drugs on the market that are effective in the population most severely affected by this parasite. This study is the first high-throughput screen for potent anti- natural products sourced from a unique marine compound library. The Harbor Branch Oceanographic Institute at Florida Atlantic University has a collection of diverse marine organisms some of which have been subjected to medium pressure liquid chromatography to create an enriched fraction library. Numerous active compounds have been discovered from this library, but it has not been tested against . A high-throughput in vitro growth inhibition assay was used to test 3764 fractions in the library, leading to the identification of 23 fractions that potently inhibited the growth of . Bioassay guided fractionation of active fractions from a deep-sea sponge, sp., resulted in the purification of leiodolide A, the major active compound in the organism. Leiodolide A displayed specific anti- activity at a half maximal effective concentration of 103.5 nM with selectivity indexes (SI) of 45.1, 11.9, 19.6 and 14.3 for human ileocecal colorectal adenocarcinoma cells (HCT-8), human hepatocellular carcinoma cells (Hep G2), human neuroblastoma cells (SH-SY5Y) and green monkey kidney cells (Vero), respectively. The unique structure of leiodolide A provides a valuable drug scaffold on which to develop new anti- compounds and supports the importance of screening natural product libraries for new chemical scaffolds.

摘要

种是顶复门寄生虫,可导致人类和有价值的牲畜严重发病甚至死亡。目前市场上没有针对受这种寄生虫严重影响人群的有效药物。本研究是首次针对来自独特海洋化合物库的有效天然产物进行高通量筛选。佛罗里达大西洋大学港岸海洋学研究所拥有各种海洋生物的集合,其中一些已经经过中压液相色谱处理,以创建富含馏分的文库。从该文库中发现了许多活性化合物,但尚未对其进行测试。本研究使用高通量体外生长抑制测定法对库中的 3764 个馏分进行了测试,结果鉴定出 23 个强烈抑制生长的馏分。从深海海绵中对活性馏分进行生物测定导向的分级分离,得到了主要活性化合物 leiodolide A。Leiodolide A 在半最大有效浓度为 103.5 nM 时显示出特定的抗活性,对人回肠结肠直肠腺癌细胞(HCT-8)、人肝癌细胞(Hep G2)、人神经母细胞瘤细胞(SH-SY5Y)和绿猴肾细胞(Vero)的选择性指数(SI)分别为 45.1、11.9、19.6 和 14.3。Leiodolide A 的独特结构为开发新型抗化合物提供了有价值的药物支架,并支持从天然产物文库中筛选新的化学支架的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7def/9026894/3b3bcaa619d6/marinedrugs-20-00240-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7def/9026894/dd83bf0699e4/marinedrugs-20-00240-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7def/9026894/efc630f6f1b2/marinedrugs-20-00240-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7def/9026894/7901c39b3684/marinedrugs-20-00240-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7def/9026894/3b3bcaa619d6/marinedrugs-20-00240-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7def/9026894/dd83bf0699e4/marinedrugs-20-00240-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7def/9026894/efc630f6f1b2/marinedrugs-20-00240-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7def/9026894/7901c39b3684/marinedrugs-20-00240-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7def/9026894/3b3bcaa619d6/marinedrugs-20-00240-g004.jpg

相似文献

1
High-Throughput Screening of a Marine Compound Library Identifies Anti- Activity of Leiodolide A.高通量筛选海洋化合物库发现 Leiodolide A 的抗活性。
Mar Drugs. 2022 Mar 30;20(4):240. doi: 10.3390/md20040240.
2
Tyrosine Kinase Inhibitors Display Potent Activity against Cryptosporidium parvum.酪氨酸激酶抑制剂对微小隐孢子虫显示出强大的活性。
Microbiol Spectr. 2023 Feb 14;11(1):e0387422. doi: 10.1128/spectrum.03874-22. Epub 2022 Dec 19.
3
A high-throughput phenotypic screen identifies clofazimine as a potential treatment for cryptosporidiosis.一项高通量表型筛选确定氯法齐明为隐孢子虫病的潜在治疗药物。
PLoS Negl Trop Dis. 2017 Feb 3;11(2):e0005373. doi: 10.1371/journal.pntd.0005373. eCollection 2017 Feb.
4
Herbicidins from Streptomyces sp. CB01388 Showing Anti- Cryptosporidium Activity.链霉菌 CB01388 产生的除草霉素具有抗隐孢子虫活性。
J Nat Prod. 2018 Apr 27;81(4):791-797. doi: 10.1021/acs.jnatprod.7b00850. Epub 2018 Feb 22.
5
Identification of Cryptosporidium parvum active chemical series by Repurposing the open access malaria box.通过重新利用开放获取的疟疾药物库鉴定微小隐孢子虫活性化学系列。
Antimicrob Agents Chemother. 2014 May;58(5):2731-9. doi: 10.1128/AAC.02641-13. Epub 2014 Feb 24.
6
Novel anti-Cryptosporidium activity of known drugs identified by high-throughput screening against parasite fatty acyl-CoA binding protein (ACBP).通过高通量筛选针对寄生虫脂肪酸酰基辅酶 A 结合蛋白 (ACBP)对已知药物进行筛选,发现其具有抗隐孢子虫的新活性。
J Antimicrob Chemother. 2012 Mar;67(3):609-17. doi: 10.1093/jac/dkr516. Epub 2011 Dec 13.
7
Discovery of ebselen as an inhibitor of Cryptosporidium parvum glucose-6-phosphate isomerase (CpGPI) by high-throughput screening of existing drugs.通过高通量筛选现有药物发现依布硒啉是微小隐孢子虫葡萄糖-6-磷酸异构酶(CpGPI)的抑制剂。
Int J Parasitol Drugs Drug Resist. 2018 Apr;8(1):43-49. doi: 10.1016/j.ijpddr.2018.01.003. Epub 2018 Jan 30.
8
Novel acyl carbamates and acyl / diacyl ureas show in vitro efficacy against Toxoplasma gondii and Cryptosporidium parvum.新型酰基氨基甲酸酯和酰基/二酰基脲类化合物对刚地弓形虫和微小隐孢子虫具有体外疗效。
Int J Parasitol Drugs Drug Resist. 2020 Dec;14:80-90. doi: 10.1016/j.ijpddr.2020.08.006. Epub 2020 Aug 25.
9
Drug repurposing screen reveals FDA-approved inhibitors of human HMG-CoA reductase and isoprenoid synthesis that block Cryptosporidium parvum growth.药物重定位筛选揭示了 FDA 批准的人 HMG-CoA 还原酶和异戊烯合成抑制剂可阻断微小隐孢子虫的生长。
Antimicrob Agents Chemother. 2013 Apr;57(4):1804-14. doi: 10.1128/AAC.02460-12. Epub 2013 Feb 4.
10
Anti-protozoal activity of Thymol and a Thymol ester against Cryptosporidium parvum in cell culture.百里酚及其酯类化合物在细胞培养中抗微小隐孢子虫的活性。
Int J Parasitol Drugs Drug Resist. 2021 Apr;15:126-133. doi: 10.1016/j.ijpddr.2021.02.003. Epub 2021 Feb 18.

引用本文的文献

1
A review of natural products as a source of next-generation drugs against apicomplexan parasites.天然产物作为抗顶复门寄生虫的下一代药物来源的综述。
NPJ Antimicrob Resist. 2025 Jun 6;3(1):51. doi: 10.1038/s44259-025-00119-x.
2
Norditerpene natural products from subterranean fungi with anti-parasitic activity.具有抗寄生虫活性的地下真菌中的降二萜类天然产物。
bioRxiv. 2025 Jan 3:2025.01.02.631097. doi: 10.1101/2025.01.02.631097.
3
Molecular Targets of the 5-Amido-Carboxamide Bumped Kinase Inhibitor BKI-1748 in and HCT-8 Host Cells.

本文引用的文献

1
Optimization of the Urea Linker of Triazolopyridazine MMV665917 Results in a New Anticryptosporidial Lead with Improved Potency and Predicted hERG Safety Margin.三氮唑并哒嗪 MMV665917 的脲连接子优化导致了一种新的抗隐孢子虫先导化合物,其效力提高,并具有预测的 hERG 安全性裕度。
J Med Chem. 2021 Aug 12;64(15):11729-11745. doi: 10.1021/acs.jmedchem.1c01136. Epub 2021 Aug 3.
2
Emerging treatment options for cryptosporidiosis.隐孢子虫病的新兴治疗选择。
Curr Opin Infect Dis. 2021 Oct 1;34(5):455-462. doi: 10.1097/QCO.0000000000000761.
3
THE EFFICACY OF MARINE NATURAL PRODUCTS AGAINST PLASMODIUM FALCIPARUM.
在 和 HCT-8 宿主细胞中 5-酰胺基羧酰胺 bumped 激酶抑制剂 BKI-1748 的分子靶标。
Int J Mol Sci. 2024 Feb 26;25(5):2707. doi: 10.3390/ijms25052707.
4
Three-Component Approach to Densely Functionalized Trifluoromethyl Allenols by Asymmetric Organocatalysis.通过不对称有机催化实现三组分方法合成全氟烷基化三氟甲基烯醇。
J Am Chem Soc. 2023 May 10;145(18):10001-10006. doi: 10.1021/jacs.3c02852. Epub 2023 Apr 26.
5
Tyrosine Kinase Inhibitors Display Potent Activity against Cryptosporidium parvum.酪氨酸激酶抑制剂对微小隐孢子虫显示出强大的活性。
Microbiol Spectr. 2023 Feb 14;11(1):e0387422. doi: 10.1128/spectrum.03874-22. Epub 2022 Dec 19.
6
The Marine Compound Tartrolon E Targets the Asexual and Early Sexual Stages of .海洋化合物Tartrolon E作用于……的无性和早期有性阶段。 (原文此处不完整)
Microorganisms. 2022 Nov 15;10(11):2260. doi: 10.3390/microorganisms10112260.
海洋天然产物抗疟原虫的功效。
J Parasitol. 2021 Mar 1;107(2):284-288. doi: 10.1645/20-93.
4
Marine-Derived Macrolides 1990-2020: An Overview of Chemical and Biological Diversity.海洋来源大环内酯类化合物 1990-2020:化学和生物多样性概述。
Mar Drugs. 2021 Mar 25;19(4):180. doi: 10.3390/md19040180.
5
Antiplasmodial Compounds from Deep-Water Marine Invertebrates.深海无脊椎动物中的抗疟化合物。
Mar Drugs. 2021 Mar 25;19(4):179. doi: 10.3390/md19040179.
6
Spontaneous Selection of Drug Resistance in a Calf Model of Infection.感染小牛模型中耐药性的自发选择。
Antimicrob Agents Chemother. 2021 May 18;65(6). doi: 10.1128/AAC.00023-21.
7
Marine natural products.海洋天然产物。
Nat Prod Rep. 2021 Mar 4;38(2):362-413. doi: 10.1039/d0np00089b.
8
Potentials of marine natural products against malaria, leishmaniasis, and trypanosomiasis parasites: a review of recent articles.海洋天然产物在抗疟疾、利什曼病和锥虫病寄生虫方面的潜力:对近期文章的综述。
Infect Dis Poverty. 2021 Jan 22;10(1):9. doi: 10.1186/s40249-021-00796-6.
9
Boromycin Has Potent Anti- and Anti- Activity.硼替佐米具有强大的抗肿瘤和抗血管生成活性。
Antimicrob Agents Chemother. 2021 Mar 18;65(4). doi: 10.1128/AAC.01278-20.
10
A symbiotic bacterium of shipworms produces a compound with broad spectrum anti-apicomplexan activity.船蛆的共生菌产生了一种具有广谱抗疟原虫活性的化合物。
PLoS Pathog. 2020 May 26;16(5):e1008600. doi: 10.1371/journal.ppat.1008600. eCollection 2020 May.